DK1636190T3 - Stabilt krystal af 4-oxoquinolinforbindelse - Google Patents

Stabilt krystal af 4-oxoquinolinforbindelse

Info

Publication number: DK1636190T3
Authority: DK; Denmark
Prior art keywords: stable crystal; oxoquinoline compound; oxoquinoline; compound; crystal
Prior art date: 2004-05-20

Application number

DK05726243.8T

Other languages

English (en)

Inventor

Motohide Satoh

Takahisa Motomura

Takashi Matsuda

Kentaro Kondo

Koji Ando

Koji Matsuda

Shuji Miyake

Hideto Uehara

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-20

Filing date

2005-05-19

Publication date

2012-09-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1636190(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-19 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2012-09-24 Application granted granted Critical

2012-09-24 Publication of DK1636190T3 publication Critical patent/DK1636190T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

DK05726243.8T 2004-05-20 2005-05-19 Stabilt krystal af 4-oxoquinolinforbindelse DK1636190T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004150979		2004-05-20
PCT/JP2005/009604 WO2005113508A1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound

Publications (1)

Publication Number	Publication Date
DK1636190T3 true DK1636190T3 (da)	2012-09-24

Family

ID=35079161

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK17186674.2T DK3281939T3 (da)	2004-05-20	2005-05-19	Kombination, der omfatter et stabilt krystal af 4-oxoquinolin sammensætning
DK05726243.8T DK1636190T3 (da)	2004-05-20	2005-05-19	Stabilt krystal af 4-oxoquinolinforbindelse

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK17186674.2T DK3281939T3 (da)	2004-05-20	2005-05-19	Kombination, der omfatter et stabilt krystal af 4-oxoquinolin sammensætning

Country Status (33)

Country	Link
US (7)	US7635704B2 (da)
EP (4)	EP3281939B1 (da)
JP (1)	JP3754064B2 (da)
KR (1)	KR20080064909A (da)
CN (1)	CN1956961B (da)
AR (2)	AR049280A1 (da)
AU (1)	AU2005245296B2 (da)
BE (1)	BE2024C511I2 (da)
BR (1)	BRPI0510114B8 (da)
CA (1)	CA2566922C (da)
CY (4)	CY1113010T1 (da)
DK (2)	DK3281939T3 (da)
ES (2)	ES2960824T3 (da)
FI (2)	FI3281939T3 (da)
FR (1)	FR23C1040I1 (da)
HR (2)	HRP20231588T3 (da)
HU (2)	HUE064615T2 (da)
IL (1)	IL179250A0 (da)
LT (2)	LT3281939T (da)
LU (1)	LUC00334I2 (da)
MX (1)	MXPA06013405A (da)
MY (1)	MY134672A (da)
NO (8)	NO339223B1 (da)
NZ (1)	NZ551839A (da)
PE (2)	PE20060358A1 (da)
PL (2)	PL1636190T3 (da)
PT (2)	PT3281939T (da)
RS (2)	RS64845B1 (da)
RU (1)	RU2330845C1 (da)
SI (2)	SI3281939T1 (da)
TW (1)	TWI329015B (da)
WO (1)	WO2005113508A1 (da)
ZA (1)	ZA200610647B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6891227B2 (en)	2002-03-20	2005-05-10	International Business Machines Corporation	Self-aligned nanotube field effect transistor and method of fabricating same
DE60329318D1 (de) *	2002-11-20	2009-10-29	Japan Tobacco Inc	4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
WO2007063869A1 (ja) *	2005-11-30	2007-06-07	Japan Tobacco Inc.	高純度キノロン化合物の製造方法
US20090233964A1 (en) *	2005-12-30	2009-09-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2013203476C1 (en) *	2005-12-30	2016-11-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
JP4676536B2 (ja) *	2005-12-30	2011-04-27	ギリアドサイエンシズ，インコーポレイテッド	Ｈｉｖインテグラーゼ阻害剤の薬物動態の改善方法
EP2452682A1 (en)	2006-02-01	2012-05-16	Japan Tobacco, Inc.	Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
WO2007092802A1 (en) *	2006-02-09	2007-08-16	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and gs 9137
CN101437801B (zh)	2006-03-06	2013-02-06	日本烟草产业株式会社	制备4-氧代喹啉化合物的方法
KR101023635B1 (ko) *	2006-03-06	2011-03-22	니뽄 다바코 산교 가부시키가이샤	4-옥소퀴놀린 화합물 제조 방법
PL2049506T5 (pl)	2006-07-07	2024-09-09	Gilead Sciences, Inc.	Modulatory farmakokinetycznych właściwości leków
EP2644587A3 (en)	2006-09-12	2013-10-23	Gilead Sciences, Inc.	Process and intermediates for preparing integrase inhibitors
EP3150586B1 (en)	2007-02-23	2020-01-08	Gilead Sciences, Inc.	Modulators of pharmacokinetic properties of therapeutics
AP2490A (en) *	2007-06-29	2012-10-04	Gilead Sciences Inc	Therapeutic compositions and the use thereof
NZ582086A (en) *	2007-06-29	2012-07-27	Gilead Sciences Inc	Therapeutic compositions and the use thereof
AR068403A1 (es) *	2007-09-11	2009-11-18	Gilead Sciences Inc	Proceso e intermediarios para la preparacion de inhibidores de integrasa
EP2296633B1 (en)	2008-05-02	2015-09-30	Gilead Sciences, Inc.	The use of solid carrier particles to improve the processability of a pharmaceutical agent
NZ594214A (en)	2009-02-06	2013-05-31	Gilead Sciences Inc	Tablets comprising cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate for combination therapy
WO2010137032A2 (en) *	2009-05-14	2010-12-02	Matrix Laboratories Ltd.	Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
WO2011004389A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	An improved process for the preparation of elvitegravir
CN102212032B (zh) *	2011-04-20	2013-07-31	复旦大学	一种5-羟基喹诺酮类衍生物及其制备方法和用途
MX2015000164A (es)	2012-07-06	2015-08-12	Genentech Inc	Benzamidas n-sustituidas y metodos para usarlas.
CA2878699C (en)	2012-08-03	2018-09-11	Gilead Sciences, Inc.	Process and intermediates for preparing integrase inhibitors
CN103819402B (zh) *	2012-11-17	2016-03-30	上海迪赛诺化学制药有限公司	埃替拉韦中间体及其制备方法和应用
CN103864682B (zh) *	2012-12-18	2016-12-28	上海迪赛诺化学制药有限公司	一种制备iii型埃替拉韦晶体的方法
NZ709260A (en)	2012-12-21	2016-07-29	Gilead Sciences Inc	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (da)	2013-07-12	2018-07-21
ES2859102T3 (es)	2013-07-12	2021-10-01	Gilead Sciences Inc	Compuestos de carbamoilpiridona policíclica y su uso para el tratamiento de infecciones por VIH
CN105315203A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种v型埃替拉韦晶体及其制备方法
NO2717902T3 (da)	2014-06-20	2018-06-23
TW201613936A (en)	2014-06-20	2016-04-16	Gilead Sciences Inc	Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI677489B (zh)	2014-06-20	2019-11-21	美商基利科學股份有限公司	多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh)	2014-12-23	2020-06-01	美商基利科學股份有限公司	多環胺甲醯基吡啶酮化合物及其醫藥用途
SI3466490T1 (sl)	2015-04-02	2020-12-31	Gilead Sciences, Inc.	Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba
CN106008195B (zh) *	2016-05-19	2018-08-03	绍兴文理学院	一种2，4-二氟-5-碘苯甲酸的制备方法
EP3984536B1 (en) *	2020-10-19	2025-06-25	Centre national de la recherche scientifique	Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472859A (en) *	1966-11-01	1969-10-14	Sterling Drug Inc	1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS567162B1 (da)	1970-09-14	1981-02-16
JPS4826772A (da)	1971-08-11	1973-04-09
JPS6450979A (en)	1987-08-21	1989-02-27	Hitachi Shipbuilding Eng Co	Method for discriminating whistle sound
JPH0651229B2 (ja)	1989-07-31	1994-07-06	新日本製鐵株式会社	プラズマアーク溶接方法および装置
IL100555A (en)	1991-02-07	2000-08-31	Hoechst Marion Roussel Inc	N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
NO304832B1 (no) *	1992-05-27	1999-02-22	Ube Industries	Aminokinolonderivater samt middel mot HIV
JP2993316B2 (ja)	1992-05-27	1999-12-20	宇部興産株式会社	アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
JPH06199835A (ja)	1993-01-08	1994-07-19	Hokuriku Seiyaku Co Ltd	８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH06271568A (ja)	1993-03-22	1994-09-27	Hokuriku Seiyaku Co Ltd	７−フェニルピペラジニルキノリン−３−カルボン酸誘導体
AU683569B2 (en) *	1994-07-18	1997-11-13	Sankyo Company Limited	Trifluoromethylquinolinecarboxylic acid derivative
JP2930539B2 (ja)	1994-07-18	1999-08-03	三共株式会社	トリフルオロメチルキノリンカルボン酸誘導体
JPH0826772A (ja)	1994-07-22	1996-01-30	Sony Corp	融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
PT892801E (pt)	1996-04-12	2002-06-28	Us Gov Health & Human Serv	Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais
FR2761687B1 (fr) *	1997-04-08	2000-09-15	Centre Nat Rech Scient	Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
JP3776203B2 (ja)	1997-05-13	2006-05-17	第一製薬株式会社	Ｉｃａｍ−１産生阻害剤
GB9721964D0 (en) *	1997-10-16	1997-12-17	Pfizer Ltd	Isoquinolines
US6399629B1 (en)	1998-06-01	2002-06-04	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
SE9802549D0 (sv) *	1998-07-15	1998-07-15	Active Biotech Ab	Quinoline derivatives
US6248736B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
US6248739B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	Quinolinecarboxamides as antiviral agents
PE20011349A1 (es)	2000-06-16	2002-01-19	Upjohn Co	1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
US6559145B2 (en) *	2000-07-12	2003-05-06	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
US20050010048A1 (en)	2000-10-12	2005-01-13	Linghang Zhuang	Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
ATE345129T1 (de)	2000-10-12	2006-12-15	Merck & Co Inc	Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
JP3616628B2 (ja) *	2001-03-01	2005-02-02	塩野義製薬株式会社	Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物
JP2002293745A (ja)	2001-03-29	2002-10-09	St Marianna Univ School Of Medicine	慢性関節リウマチ治療剤
US20030138483A1 (en) *	2001-05-25	2003-07-24	Sergio Petriconi	Soft elastic capsules and compositions thereof
US6627646B2 (en) *	2001-07-17	2003-09-30	Sepracor Inc.	Norastemizole polymorphs
FR2827600A1 (fr)	2001-07-20	2003-01-24	Lipha	Derives acides de quinolone et leurs applications en therapeutique
RU2206564C1 (ru) *	2002-03-07	2003-06-20	Общество с ограниченной ответственностью "Поливит"	Способ получения этилового эфира 6-фтор-7-хлор-1,4-дигидро-4-оксо-3-хинолинкарбоновой кислоты
JP4035765B2 (ja)	2002-10-31	2008-01-23	横河電機株式会社	フーリエ変換型赤外線分光計
JP3567162B1 (ja)	2002-11-20	2004-09-22	日本たばこ産業株式会社	４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
DE60329318D1 (de) *	2002-11-20	2009-10-29	Japan Tobacco Inc	4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
WO2005113509A1 (en) *	2004-05-20	2005-12-01	Japan Tobacco Inc.	Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
US8633219B2 (en) *	2004-05-21	2014-01-21	Japan Tobacco Inc.	Combination therapy

2005
- 2005-05-18 MY MYPI20052258A patent/MY134672A/en unknown
- 2005-05-19 MX MXPA06013405A patent/MXPA06013405A/es active IP Right Grant
- 2005-05-19 NZ NZ551839A patent/NZ551839A/en not_active IP Right Cessation
- 2005-05-19 ES ES17186674T patent/ES2960824T3/es not_active Expired - Lifetime
- 2005-05-19 HR HRP20231588TT patent/HRP20231588T3/hr unknown
- 2005-05-19 PT PT171866742T patent/PT3281939T/pt unknown
- 2005-05-19 JP JP2005147219A patent/JP3754064B2/ja not_active Expired - Lifetime
- 2005-05-19 PL PL05726243T patent/PL1636190T3/pl unknown
- 2005-05-19 LT LTEP17186674.2T patent/LT3281939T/lt unknown
- 2005-05-19 FI FIEP17186674.2T patent/FI3281939T3/fi active
- 2005-05-19 EP EP17186674.2A patent/EP3281939B1/en not_active Expired - Lifetime
- 2005-05-19 ZA ZA200610647A patent/ZA200610647B/en unknown
- 2005-05-19 AR ARP050102058A patent/AR049280A1/es not_active Application Discontinuation
- 2005-05-19 DK DK17186674.2T patent/DK3281939T3/da active
- 2005-05-19 CN CN2005800161426A patent/CN1956961B/zh not_active Expired - Lifetime
- 2005-05-19 ES ES05726243T patent/ES2388441T3/es not_active Expired - Lifetime
- 2005-05-19 TW TW094116234A patent/TWI329015B/zh not_active IP Right Cessation
- 2005-05-19 EP EP05726243A patent/EP1636190B1/en not_active Expired - Lifetime
- 2005-05-19 AU AU2005245296A patent/AU2005245296B2/en active Active
- 2005-05-19 SI SI200532315T patent/SI3281939T1/sl unknown
- 2005-05-19 PL PL17186674.2T patent/PL3281939T3/pl unknown
- 2005-05-19 WO PCT/JP2005/009604 patent/WO2005113508A1/en not_active Ceased
- 2005-05-19 HR HRP20120681TT patent/HRP20120681T1/hr unknown
- 2005-05-19 SI SI200531572T patent/SI1636190T1/sl unknown
- 2005-05-19 CA CA2566922A patent/CA2566922C/en not_active Expired - Lifetime
- 2005-05-19 BR BRPI0510114A patent/BRPI0510114B8/pt active IP Right Grant
- 2005-05-19 EP EP23203885.1A patent/EP4299563A3/en active Pending
- 2005-05-19 HU HUE17186674A patent/HUE064615T2/hu unknown
- 2005-05-19 KR KR1020087014768A patent/KR20080064909A/ko not_active Withdrawn
- 2005-05-19 RS RS20231092A patent/RS64845B1/sr unknown
- 2005-05-19 RU RU2006145302/04A patent/RU2330845C1/ru active
- 2005-05-19 RS RS20120306A patent/RS52375B/sr unknown
- 2005-05-19 EP EP12173572A patent/EP2514746A1/en not_active Withdrawn
- 2005-05-19 PT PT05726243T patent/PT1636190E/pt unknown
- 2005-05-19 DK DK05726243.8T patent/DK1636190T3/da active
- 2005-05-20 PE PE2005000561A patent/PE20060358A1/es active IP Right Grant
- 2005-05-20 PE PE2011002129A patent/PE20120361A1/es active IP Right Grant
- 2005-05-20 US US11/133,471 patent/US7635704B2/en active Active
2006
- 2006-11-14 IL IL179250A patent/IL179250A0/en active IP Right Grant
- 2006-12-14 NO NO20065790A patent/NO339223B1/no unknown
2009
- 2009-08-10 US US12/538,694 patent/US8981103B2/en active Active
2012
- 2012-07-11 CY CY20121100621T patent/CY1113010T1/el unknown
2014
- 2014-04-25 AR ARP140101722A patent/AR096100A2/es active IP Right Grant
2015
- 2015-01-09 US US14/593,946 patent/US20150361044A1/en not_active Abandoned
2016
- 2016-08-12 NO NO20161297A patent/NO20161297A1/no not_active Application Discontinuation
2017
- 2017-03-01 US US15/447,007 patent/US20180029989A1/en not_active Abandoned
2018
- 2018-07-20 US US16/041,458 patent/US20190185433A1/en not_active Abandoned
2019
- 2019-01-15 NO NO20190051A patent/NO20190051A1/no not_active Application Discontinuation
2020
- 2020-08-04 NO NO20200873A patent/NO20200873A1/no not_active Application Discontinuation
2021
- 2021-08-24 US US17/445,817 patent/US20220235009A1/en not_active Abandoned
2022
- 2022-06-17 NO NO20220690A patent/NO20220690A1/no not_active Application Discontinuation
2023
- 2023-08-25 NO NO20230913A patent/NO347902B1/no unknown
- 2023-09-28 CY CY2015009C patent/CY2015009I1/el unknown
- 2023-11-02 FR FR23C1040C patent/FR23C1040I1/fr active Active
- 2023-12-05 CY CY20231100714T patent/CY1126560T1/el unknown
2024
- 2024-03-14 LU LU00334C patent/LUC00334I2/fr unknown
- 2024-03-15 BE BE2024C511C patent/BE2024C511I2/nl unknown
- 2024-03-19 CY CY2024008C patent/CY2024008I1/el unknown
- 2024-03-20 HU HUS2400006C patent/HUS2400006I1/hu unknown
- 2024-03-20 FI FIC20240008C patent/FIC20240008I1/fi unknown
- 2024-03-26 LT LTPA2024001C patent/LTC3281939I2/lt unknown
- 2024-04-12 US US18/634,451 patent/US20250091995A1/en active Pending
- 2024-04-22 NO NO20240384A patent/NO20240384A1/no unknown
- 2024-07-15 NO NO2024034C patent/NO2024034I1/no unknown

Also Published As

Publication number	Publication date
CA2566922C (en)	2011-01-11
NO347902B1 (no)	2024-05-06
AR049280A1 (es)	2006-07-12
NO20065790L (no)	2007-02-07
NO20220690A1 (no)	2007-02-07
EP4299563A2 (en)	2024-01-03
IL179250A0 (en)	2007-03-08
KR20080064909A (ko)	2008-07-09
WO2005113508A1 (en)	2005-12-01
HUE064615T2 (hu)	2024-04-28
FR23C1040I1 (fr)	2023-12-29
CN1956961B (zh)	2010-05-26
PT3281939T (pt)	2023-11-22
PT1636190E (pt)	2012-08-20
CA2566922A1 (en)	2005-12-01
CN1956961A (zh)	2007-05-02
RU2330845C1 (ru)	2008-08-10
US20060030710A1 (en)	2006-02-09
BRPI0510114B8 (pt)	2021-05-25
NO20240384A1 (no)	2007-02-07
EP3281939B1 (en)	2023-10-18
ES2388441T3 (es)	2012-10-15
BRPI0510114B1 (pt)	2020-09-15
NO2024034I1 (no)	2024-07-15
AU2005245296A1 (en)	2005-12-01
EP1636190B1 (en)	2012-06-27
NO20200873A1 (no)	2007-02-07
NO339223B1 (no)	2016-11-21
CY2024008I2 (el)	2024-09-20
MY134672A (en)	2007-12-31
LT3281939T (lt)	2023-11-27
CY2024008I1 (el)	2024-09-20
RS52375B (sr)	2012-12-31
EP1636190A1 (en)	2006-03-22
US20220235009A1 (en)	2022-07-28
LTC3281939I2 (da)	2025-04-25
FIC20240008I1 (fi)	2024-03-20
BRPI0510114A (pt)	2007-09-25
PL1636190T3 (pl)	2012-10-31
LUC00334I2 (da)	2024-07-01
PL3281939T3 (pl)	2024-03-18
HRP20231588T3 (hr)	2024-03-15
HUS2400006I1 (hu)	2024-04-28
US20100204271A1 (en)	2010-08-12
TW200600097A (en)	2006-01-01
HRP20120681T1 (hr)	2012-09-30
US20190185433A1 (en)	2019-06-20
NO20161297A1 (no)	2007-02-07
HK1083341A1 (en)	2006-06-30
JP3754064B2 (ja)	2006-03-08
US20250091995A1 (en)	2025-03-20
BE2024C511I2 (da)	2024-10-08
CY1113010T1 (el)	2016-04-13
AU2005245296B2 (en)	2010-08-12
PE20120361A1 (es)	2012-05-03
EP2514746A1 (en)	2012-10-24
JP2006001927A (ja)	2006-01-05
CY2015009I2 (el)	2024-09-20
RS64845B1 (sr)	2023-12-29
NO20190051A1 (no)	2007-02-07
EP3281939A1 (en)	2018-02-14
CY1126560T1 (el)	2024-09-20
US8981103B2 (en)	2015-03-17
LTPA2024001I1 (da)	2024-04-10
US20180029989A1 (en)	2018-02-01
US20150361044A1 (en)	2015-12-17
SI1636190T1 (sl)	2012-09-28
PE20060358A1 (es)	2006-05-12
SI3281939T1 (sl)	2024-02-29
US7635704B2 (en)	2009-12-22
FI3281939T3 (fi)	2023-10-23
CY2015009I1 (el)	2024-09-20
DK3281939T3 (da)	2024-01-22
AR096100A2 (es)	2015-12-09
ES2960824T3 (es)	2024-03-06
ZA200610647B (en)	2008-06-25
MXPA06013405A (es)	2007-03-01
EP4299563A3 (en)	2024-02-28
TWI329015B (en)	2010-08-21
NZ551839A (en)	2009-11-27
NO20230913A1 (no)	2007-02-07

Publication	Publication Date	Title
DK1636190T3 (da)	2012-09-24	Stabilt krystal af 4-oxoquinolinforbindelse
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK1992697T3 (da)	2010-05-17	Fremstilling af TNFR-Fc
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK2363414T3 (da)	2022-08-08	Stedstyret modifikation af FVIII
DK1831154T3 (da)	2010-04-12	Fremstilling af pregabalin og relaterede forbindelser
DK2377869T3 (da)	2014-04-14	Syntese af Bortezomib
DK1877568T4 (da)	2021-01-11	Hydrolysering af arabinoxylan
DK1778672T3 (da)	2013-03-25	Krystallinsk form af en biphenylforbindelse
DK1937071T3 (da)	2011-11-28	Krystallinske modifikationer af pyraclostrobin
DK1846566T3 (da)	2013-07-01	Stabile nåleformede krystaller af natamycin
DK1710245T3 (da)	2007-12-03	Krystalform af asenapinmaleat
DK1587542T3 (da)	2012-07-30	Anvendelse af anti-CD100-antistoffer
DK1840125T3 (da)	2009-11-09	Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK2083629T3 (da)	2011-09-26	Krystallinsk modifikation af fipronil
DK1940465T3 (da)	2012-10-22	Ny anvendelse af anti-IL-1beta-antistoffer
DK1917227T3 (da)	2013-05-27	Krystalformer af astaxanthin
DK2371818T3 (da)	2013-03-25	Hydroxybenzoatsalte af metanikotinforbindelser
DK1874766T3 (da)	2010-12-06	Krystallinsk form af en quinolinon-carboxamid-forbindelse
DK1763520T3 (da)	2009-02-09	Anvendelse af trisubstituerede benzopyranoner
DE502005005664D1 (de)	2008-11-27	Chronograph
DK1727782T3 (da)	2012-10-08	Fremgangsmåde til fremstilling af aminophenolforbindelser
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin